The Patent Finder

WRN Inhibitors

Nimbus Wadjet, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 18/738,470, filed Jun 10, 2024. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 12,344,609WRN Inhibitors
In force
 · Medium confidence
UsedRemaining
Nimbus Wadjet, Inc.In forceMedium confidence
US 12,421,233WRN Inhibitors
In force
 · Medium confidence
Nimbus Wadjet, Inc.In forceMedium confidence
US 12,528,806WRN Inhibitors
In force
 · Low confidence
Nimbus Wadjet, Inc.In forceLow confidence
Application 18/738,470WRN Inhibitors
Pending
Not granted
Nimbus Wadjet, Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Nimbus Wadjet, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited